Cerecor Inc., of Baltimore, appointed James Vornov senior vice president, clinical development and regulatory affairs, and John Kaiser vice president of commercialization and business development...Durata Therapeutics Inc., of Morristown, N.J., named Allison Wey vice president of investor relations and public affairs...Fate Therapeutics Inc., of San Diego, appointed Christian Weyer president and CEO

Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board...Kinex Pharmaceuticals LLC, of Buffalo, N.Y., named Patrick Gallagher vice president, business development and investor relations

Vaximm AG, of Basel, Switzerland, and Mannheim, Germany, appointed Jean Paul Prieels to its board...Watson Pharmaceuticals Inc., of Parsippany, N.J., appointed Lisa DeFrancesco vice president, global investor relations...Ziopharm Oncology Inc., of New York, appointed Jason Amello executive vice president and chief financial officer

Alnylam Pharmaceuticals Inc., of Cambridge, Mass., named Cynthia Clayton vice president of investor relations and corporate communications...and Christine Mikail, executive vice president, corporate development, general counsel and secretary

Ascletis Inc., of Research Triangle Park, N.C., and Hangzhou, China, appointed Allan Baxter chief strategy officer...Celsion Corp., of Columbia, Md., appointed Gregory Weaver senior vice president and chief financial officer and promoted Jeffery Church to senior vice president of strategy and investor relations

Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...BioInvent International AB, of Lund, Sweden, appointed Sten Westerberg vice president of investor relations

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...Pernix Therapeutics Holdings Inc., of Magnolia, Texas, appointed Joseph T. Schepers director of investor relations and corporate communications...Zealand Pharma A/S, of Copenhagen, Denmark, appointed Hanne Leth Hillman vice president of investor relations and corporate communications

Neovacs, of Paris, appointed Florence Hocdee-Leroy communications and investor relations director

and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Maria E. Cantor vice president of corporate communications and investor relations...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Sucampo Pharmaceuticals Inc., of Bethesda, Md., named Kathryn de Santis vice president of investor relations and corporate communications...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board

GenVault Corp., of Carlsbad, Calif., named Myla P. Lai-Goldman and Jack Ballantyne to its scientific advisory board...MediGene AG, of Martinsried, Germany, said Thomas Strüngmann and Mathias Albert Boehringer were elected as new supervisory board members...Mylan Inc., of Pittsburgh, appointed Daniel E. Crookshank vice president of investor relations

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Georges Gemayel, CEO and member of the board...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Raymond T. Keane vice president, general counsel and chief compliance officer...Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., named Blaine T. Davis vice president of investor relations and corporate communications

Oragenics Inc., of Alachua, Fla., named Marc Siegel and Kevin Sills to its board...Speedel, of Basel, Switzerland, appointed Harald F. Schafer head of corporate communications and investor relations

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Justine E. Koenigsberg senior director of corporate communications and investor relations...GeneNews Ltd., of Toronto, elected Harry A. Glorikian and Fran Tuttle to its board

Seattle Genetics, of Bothell, Wash., added John P. McLaughlin and Daniel G. Welch to its board of directors...Xechem International Inc., of New Brunswick, N.J., named H. Scott English internal director of investor relations and Benjamin S. White III the director of finance and accounting

It also named Tim Warner senior vice president, investor relations and corporate affairs...Stephan Herrera senior director, investor relations and corporate affairs

Advanced Magnetics Inc., of Cambridge, Mass., appointed Kristen Galfetti senior director, investor relations...plc, of Dublin, Ireland, is bringing on Floyd Bloom and Jeff Shames as non-executive members of the board...Icagen Inc., of Research Triangle Park, N.C., appointed Christopher Cimarusti and Ian Skidmore as the initial members of a new drug discovery and development expert panel

Sue Stansfield senior vice president of clinical operations and project management for Europe...and Randy Marchbanks vice president of business development for the Americas...RegImmune Corp., of Mountain View, Calif., and Tokyo, appointed Shirley Liu Clayton as a nonexecutive director